These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24992667)

  • 1. A flow-through chromatography process for influenza A and B virus purification.
    Weigel T; Solomaier T; Peuker A; Pathapati T; Wolff MW; Reichl U
    J Virol Methods; 2014 Oct; 207():45-53. PubMed ID: 24992667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A membrane-based purification process for cell culture-derived influenza A virus.
    Weigel T; Solomaier T; Wehmeyer S; Peuker A; Wolff MW; Reichl U
    J Biotechnol; 2016 Feb; 220():12-20. PubMed ID: 26712479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic-interaction chromatography for purification of influenza A and B virus.
    Weigel T; Soliman R; Wolff MW; Reichl U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():103-117. PubMed ID: 31005703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of cell culture-derived influenza A virus via continuous anion exchange chromatography on monoliths.
    Fischer LM; Wolff MW; Reichl U
    Vaccine; 2018 May; 36(22):3153-3160. PubMed ID: 28729020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) in the process of vaccine production.
    Sakoda Y; Okamatsu M; Isoda N; Yamamoto N; Ozaki K; Umeda Y; Aoyama S; Kida H
    Microbiol Immunol; 2012 Jul; 56(7):490-5. PubMed ID: 22530951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent.
    Opitz L; Zimmermann A; Lehmann S; Genzel Y; Lübben H; Reichl U; Wolff MW
    J Virol Methods; 2008 Dec; 154(1-2):61-8. PubMed ID: 18840469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle quantification of influenza viruses by high performance liquid chromatography.
    Transfiguracion J; Manceur AP; Petiot E; Thompson CM; Kamen AA
    Vaccine; 2015 Jan; 33(1):78-84. PubMed ID: 25448111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography.
    Tseng YF; Weng TC; Lai CC; Chen PL; Lee MS; Hu AY
    Vaccine; 2018 May; 36(22):3146-3152. PubMed ID: 28342667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
    Opitz L; Lehmann S; Reichl U; Wolff MW
    Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and strategies of cell-culture technology for influenza vaccine.
    Feng SZ; Jiao PR; Qi WB; Fan HY; Liao M
    Appl Microbiol Biotechnol; 2011 Feb; 89(4):893-902. PubMed ID: 21063703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving history of influenza viruses and influenza vaccines.
    Hannoun C
    Expert Rev Vaccines; 2013 Sep; 12(9):1085-94. PubMed ID: 24024871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
    Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
    J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
    Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW
    Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography.
    Kalbfuss B; Wolff M; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 Apr; 96(5):932-44. PubMed ID: 16937411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9).
    Fei C; Gao J; Fei C; Ma L; Zhu W; He L; Wu Y; Song S; Li W; Zhou J; Liao G
    J Virol Methods; 2022 Mar; 301():114408. PubMed ID: 34896455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous and complete genome sequencing of influenza A and B with high coverage by Illumina MiSeq Platform.
    Rutvisuttinunt W; Chinnawirotpisan P; Simasathien S; Shrestha SK; Yoon IK; Klungthong C; Fernandez S
    J Virol Methods; 2013 Nov; 193(2):394-404. PubMed ID: 23856301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAP, a new human suspension cell line for influenza virus production.
    Genzel Y; Behrendt I; Rödig J; Rapp E; Kueppers C; Kochanek S; Schiedner G; Reichl U
    Appl Microbiol Biotechnol; 2013 Jan; 97(1):111-22. PubMed ID: 22821436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous purification of influenza virus using simulated moving bed chromatography.
    Kröber T; Wolff MW; Hundt B; Seidel-Morgenstern A; Reichl U
    J Chromatogr A; 2013 Sep; 1307():99-110. PubMed ID: 23932371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obtaining concentrated influenza virus preparations by adsorption liquid chromatography].
    Polianskaia NIu; Oganova NIu
    Tr Inst Im Pastera; 1979; 52():99-103. PubMed ID: 550554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.